Improving The Lives Of Patients Is What Drives Us
Our organisation spans the entire value chain in the U.K.: research and development (R&D), manufacturing and distribution, plus commercial operations. The U.K contributes significantly to our business, with global specialised toxin production taking place at our site in Wrexham, and commercial and corporate activities and functions housed at our London site.
Our sites in the U.K.
London, England
Our U.K. HQ for commercial operations
Ipsen’s site in London is one of our three international commercial hubs, housing state-of-the-art facilities. Located here are many of our corporate functions, spanning both U.K.-specific and international capabilities in commercial, technical operations, research and development, medical, and support functions.
We pride ourselves on offering exceptional people a great place to work in the heart of the Paddington Life Sciences cluster.
At a glance
- Address: 5th Floor The Point, 37 North Wharf Road, London, W2 1AF
- Over 300 employees
- One of three Global hubs for Ipsen, alongside France and the U.S.
- Oversees R&D, manufacturing and commercial operations
- Functions – technical operations, speciality care, R&D and corporate functions. This site also serves as a hub for some of our international business operations.
Wrexham, Wales
Our U.K. HQ for development and manufacturing
Our Wrexham site in the U.K. is our neuroscience centre of excellence, responsible for developing and manufacturing neurotoxin research with the ambition of providing continued innovation for patients.
At a glance
- Nearly 500 employees
- Our largest U.K. site, overseeing manufacturing, API development and fill-finish facilities
- £102 million investment since 2022, including a new £27 million flexible drug product manufacturing facility
- 100% powered by renewable electric
Wrexham is committed to sustainable working, with the aims to reduce carbon intensity by 50% by 2025. Ipsen Wrexham is the first site in the U.K. & Ireland to use 100% renewable power, with the aspiration that the site will support the production and export of Ipsen medicines across the word in a sustainable manner. Currently, futher investment and expansion of the site is being explored, with a potential for a Science Academy.
Our Partnerships And Contributions
At Ipsen, we strive to be a creative and like-minded partner of choice. We believe that achieving the best results for patients depends on our ability to work effectively and ethically in partnership with those around us, including healthcare professionals, the NHS, patient groups, policy makers and government.
Our partnerships and contributionsIpsen’s Milestones
2024
Ipsen opens new U.K. commercial headquarters in Paddington, London
Wrexham and London sites certified as U.K. Best Workplaces by Great Place to Work
Wrexham site receives several accolades, including the U.K. Pharma Awards for Project of the Year (Small), HR Achievement Award, and Pharma Company of the Year, as well as the Made in Wales – Manufacturer of the Year award
Dublin site receives the prestigious Shingo Prize and the Silver Award from the Irish Centre for Diversity
2023
Ipsen’s Wrexham facility voted one of U.K.’s Best Workplaces™
Dublin site recognised as a Great Place to Work, a Great Place to Work in Pharma, and receives the Bronze Award from the Irish Centre for Diversity
Wrexham site receives the U.K. Pharma Award for Project of the Year and the Made in Wales – Medical Life Sciences & Healthcare Award
2022
Ipsen Global sales total over €3bn for the first time
Wrexham and London sites recognised as a Best Workplaces Large Employer, a Best Workplace for Women, and a Best Workplace for Wellbeing, all awarded by Great Place to Work
2021
Ipsen commits to The Business Ambition for 1.5°C initiative, aiming for net zero value-chain greenhouse gas emissions by 2050
2018
Ipsen sales total over €2bn for the first time
CRSC-GB-000205
October 2025